CLEAN : China grants 'conditional' market approval for Covid vaccine

The video discusses the approval of a COVID-19 vaccine by the Chinese authorities, highlighting the vaccine's production capacity to meet domestic demand and its free provision to the public. It emphasizes the rigorous evaluation process the vaccine underwent, concluding that its benefits outweigh the risks, meeting the standards for conditional market approval.

On what date did the national authority approve the registration application for Sinopharm's COVID-19 vaccine?

• December 31st

• December 30th

• December 29th

• December 28th

What is the main assurance given about China's COVID-19 vaccine production capacity?

• It will be available only in urban areas.

• It will be produced in limited quantities.

• It can meet domestic large-scale vaccination needs.

• It will be exported to other countries.

How will the COVID-19 vaccine be provided to the public in China?

• At a subsidized cost

• For a small fee

• Free of charge

• Through private clinics only

What was the conclusion of the review process regarding the vaccine's benefits and risks?

• The risks outweigh the benefits.

• The benefits and risks are equal.

• The benefits outweigh the risks.

• The risks are unknown.

What standard did the vaccine meet to receive conditional market approval?

• Basic safety checks

• Conditional market approval standards

• Preliminary testing

• International guidelines